HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Cyr Selected Research

Insulin (Novolin)

3/2008Impaired plasma nonesterified fatty acid tolerance is an early defect in the natural history of type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Cyr Research Topics

Disease

2Fabry Disease (Fabry's Disease)
08/2007 - 02/2007
1Insulin Resistance
03/2009
1Type 2 Diabetes Mellitus (MODY)
03/2008
1Methylmalonic acidemia
08/2007
1Cystinuria
08/2007
1Fanconi Syndrome (Syndrome, Fanconi)
08/2007
1Gamma-cystathionase deficiency
08/2007
1Prolidase Deficiency
08/2007
1Inborn Urea Cycle Disorders
08/2007
1Argininosuccinic Aciduria
08/2007

Drug/Important Bio-Agent (IBA)

2Fatty Acids (Saturated Fatty Acids)IBA
03/2009 - 03/2008
2Triglycerides (Triacylglycerol)IBA
03/2009 - 03/2008
2Nonesterified Fatty Acids (NEFA)IBA
03/2009 - 03/2008
2globotriaosylceramide (globotriosylceramide)IBA
08/2007 - 02/2007
1Insulin (Novolin)FDA Link
03/2008
1Amino AcidsFDA Link
08/2007
1Indicators and Reagents (Reagents)IBA
08/2007
1GlycosphingolipidsIBA
02/2007
1Biomarkers (Surrogate Marker)IBA
02/2007
1alpha-Galactosidase (Beano)IBA
02/2007
1EnzymesIBA
02/2007